Comparison efficacy for termination of early pregnancy failure by mifepristone followed by misoprostol with misoprostol alone : A Randomized Double-Blind Placebo- Controlled Trial
Phase 2
Active, not recruiting
- Conditions
- pregnancy failure
- Registration Number
- TCTR20180825005
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- Female
- Target Recruitment
- 92
Inclusion Criteria
-pregnancy GA < 12 wk
-pregnancy failure
-vital sign stable
-accepted to follow this research
Exclusion Criteria
-inevitable or incomplete abortion
-vital sign unstable
-Hemoglobin < 8 mg%
-coagulopathy
-suspected sepsis
-history of mifepristone or misoprostal allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method complete abortion 2 day after intervention[ cytotec vaginal suppository] trans vaginal ultrasound for evaluate endometrial thickness [ET] and blind operator& participant
- Secondary Outcome Measures
Name Time Method satisfaction of patient 2 day after intervention[ cytotec vaginal suppository] Patient reported outcome using a questionnaire interview